Edarbi Dosage & Drug Information

Concise Prescribing Info

Contents

Azilsartan medoxomil (as K)

Indications/Uses

Essential HTN in adults.

Dosage/Direction for Use

Initially 40 mg once daily. May be increased to a max of 80 mg once daily as necessary.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity. Concomitant use w/ aliskiren. Pregnancy (2nd & 3rd trimester).

Special Precautions

CHF, severe renal & hepatic impairment, ESRD, renal artery stenosis. Ischaemic cardiomyopathy or ischaemic cerebrovascular disease. Vol- &/or salt-depleted patients, primary hyperaldosteronism. Monitor serum K in patients taking K-sparing diuretics, salt substitutes containing K & drugs that increase K levels (eg, heparin) & creatinine levels in patients w/ renal impairment & DM. Aortic or mitral valve stenosis, hypertrophic obstructive cardiomyopathy.

Adverse Reactions

Dizziness, diarrhoea, increased blood creatinine.

View ADR Monitoring Form

Drug Interactions

Reversibly increases serum conc & toxicity of lithium; attenuated antihypertensive effects & risk of worsening of renal function may occur w/ NSAIDs. Hyperkalemia w/ K-sparing diuretics & K supplements.

MIMS Class

Angiotensin II Antagonists

ATC Classification

C09CA09 - azilsartan medoxomil ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.

Thai FDA Category

Presentation/Packing

Form

Edarbi tab 40 mg

Packing/Price

2 × 14's

Form

Edarbi tab 80 mg

Packing/Price

2 × 14's

Edarbi

Manufacturer:

Celltrion Healthcare

Distributor:

Zuellig Pharma